SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-006899
Filing Date
2021-06-15
Accepted
2021-06-15 09:01:17
Documents
2
Period of Report
2021-06-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ndra_8k.htm 8-K 30993
2 PRESS RELEASE ndra_ex991.htm EX-99.1 13960
  Complete submission text file 0001654954-21-006899.txt   46290
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 211017026
SIC: 3845 Electromedical & Electrotherapeutic Apparatus